Send feedback

DNMT1 p.Thr174Pro

c.520A>C · rs201319352 · VCV472279

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 5 submitters
AlphaMissense
likely benign
0.1113 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00246%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
hereditary sensory neuropathy-deafness-dementia syndrome

Computational evidence

Protein change
AlphaMissense0.1113likely benign
REVEL0.086moderately benign-leaning
SaProtLLR -8.21tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 3.4GERP 4.4, phastCons 1
Regional constrainto/e 0.87unconstrained · MANE · 35 kb · p 0.0067 · regional, not allelic
Overall
CADD22.6PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM T158P vs ClinVar T174P) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00246% European (non-Finnish) · 29/1,179,982 alleles
Filtering AF 0.00172% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00149%
Overall 0.00942% 152/1,613,626 alleles · very rare exomes 138/1,461,850 · genomes 14/151,776 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.365% 274
Remaining individualsnot grpmax-eligible 0.024% 4,165
European (non-Finnish)grpmax 0.00246% 40,689

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
DNMT1
Protein
p.Thr174Pro
Coding
c.520A>C
MANE Select
NM_001130823
dbSNP
rs201319352
Type
single nucleotide variant
Location
chr19:10177341 (GRCh38)
Gene constraint
LOEUF 0.15 · pLI 1.00 (gnomAD)
Structure
AlphaFold pLDDT 77.88 · 29 PDB
Residue 158 UniProt numbering
the 'interaction with the prc2/eed-ezh2 complex' region; the 'disordered' region; the 'interaction with dnmt3b' region
Full DNMT1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary sensory neuropathy-deafness-dementia syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Hereditary sensory neuropathy-deafness-dementia syndrome (Orphanet):

Inheritance
Autosomal dominant
Onset
Adolescent, Adult

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dnmt1-p-thr174pro (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown